Carol Beard, Ph.D. - Publications

Affiliations: 
2011 Western Michigan University, Kalamazoo, MI, United States 
Area:
Health Education, Nursing, Theory and Methods

0/276 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2019 Muralidhar V, Nguyen PL, Mahal BA, Yang DD, Mouw KW, Rose BS, Beard CJ, Efstathiou JA, Martin NE, King MT, Orio PF. Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 941-948. PMID 31390585 DOI: 10.6004/Jnccn.2018.7283  0.01
2019 Abu Zaid M, Dinh PC, Monahan PO, Fung C, El-Charif O, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Sesso HD, Huddart R, Mushiroda T, et al. Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 459-468. PMID 31085753 DOI: 10.6004/jnccn.2018.7109  0.01
2018 King MT, Nguyen PL, Boldbaatar N, Tempany CM, Cormack RA, Beard CJ, Hurwitz MD, Suh WW, D'Amico AV, Orio PF. Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer. Cancer. PMID 29975404 DOI: 10.1002/cncr.31568  0.01
2018 Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, et al. Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017770735. PMID 29617189 DOI: 10.1200/Jco.2017.77.0735  0.01
2018 Dinh KT, Aizer AA, Muralidhar V, Mahal BA, Chen YW, Beard CJ, Choueiri TK, Hoffman KE, Hu JC, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce. The American Journal of Medicine. PMID 29555248 DOI: 10.1016/j.amjmed.2017.11.039  0.01
2018 Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, et al. Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score. Clinical Genitourinary Cancer. PMID 29534941 DOI: 10.1016/j.clgc.2018.01.011  0.01
2018 Zaid MA, Gathirua-Mwangi WG, Fung C, Monahan PO, El-Charif O, Williams AM, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse SK, Ardeshir-Rouhani-Fard S, Dinh PC, Sesso HD, et al. Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 257-265. PMID 29523664 DOI: 10.6004/jnccn.2017.7046  0.01
2018 Muralidhar V, Yang DD, Mahal BAV, Rose BS, Beard C, Efstathiou JA, King MT, Martin NE, Orio PF, Nguyen PL. Practice patterns and outcomes among patients with N0M0 prostate cancer and a very high prostate-specific antigen. Journal of Clinical Oncology. 36: 48-48. DOI: 10.1200/JCO.2018.36.6_SUPPL.48  0.01
2018 King MT, Nguyen PL, Boldbaatar N, Tempany CM, Cormack RA, Beard C, Hurwitz M, Suh W, D'Amico AV, Orio PF. Long-term outcomes of magnetic resonance image-guided partial prostate brachytherapy for favorable-risk prostate cancer. Journal of Clinical Oncology. 36: 138-138. DOI: 10.1200/JCO.2018.36.6_SUPPL.138  0.01
2018 King M, Nguyen P, Boldbaatar N, Yang D, Cormack R, Beard C, Hurwitz M, Suh W, Tempany C, DAmico A, Orio P. PSA Velocity before Biochemical Failure is Associated with Distant Metastasis after Partial Prostate Treatment with Brachytherapy International Journal of Radiation Oncology*Biology*Physics. 102: e122. DOI: 10.1016/J.IJROBP.2018.07.328  0.01
2017 Yang DD, Muralidhar V, Mahal BA, Beard CJ, Mouw KW, Martin NE, Orio PF, King MT, Nguyen PL. Travel Distance as a Barrier to Receipt of Adjuvant Radiation Therapy After Radical Prostatectomy. American Journal of Clinical Oncology. PMID 29045266 DOI: 10.1097/Coc.0000000000000410  0.01
2017 O'Donnell E, Markt SC, Miller R, Bernard B, Albiges L, Beard C, Sweeney C. Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors. Clinical Genitourinary Cancer. PMID 28851592 DOI: 10.1016/j.clgc.2017.07.024  0.01
2017 Yang DD, Mahal BA, Muralidhar V, Boldbaatar N, Labe SA, Nezolosky MD, Vastola ME, Beard CJ, Martin NE, Mouw KW, Orio PF, King MT, Nguyen PL. Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer. Cancer. PMID 28832984 DOI: 10.1002/Cncr.30948  0.01
2017 Yang DD, Mahal BA, Muralidhar V, Nezolosky MD, Vastola ME, Labe SA, Boldbaatar N, King MT, Martin NE, Orio PF, Beard CJ, Hoffman KE, Trinh QD, Spratt DE, Feng FY, et al. Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer. European Urology Focus. PMID 28753811 DOI: 10.1016/j.euf.2017.05.011  0.01
2017 Kamran SC, Harshman LC, Bhagwat MS, Muralidhar V, Nguyen PL, Martin NE, La Follette S, Faso S, Viswanathan AN, Efstathiou JA, Beard CJ. Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experience. Advances in Radiation Oncology. 2: 140-147. PMID 28740925 DOI: 10.1016/j.adro.2017.01.001  0.01
2017 Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. European Urology. PMID 28687143 DOI: 10.1016/j.eururo.2017.06.013  0.01
2017 Howard SA, Rosenthal MH, Qin L, Matalon SA, Bernard BD, Beard CJ, Sweeney CJ. Quantifying Decreased Radiation Exposure From Modern CT Scan Technology and Surveillance Programs of Germ Cell Tumors. American Journal of Clinical Oncology. PMID 28654572 DOI: 10.1097/COC.0000000000000399  0.01
2017 Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton R, Vaughn DJ, Beard C, Fung C, Fossa SD, Hertz DL, Mushiroda T, Kubo M, et al. Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28611204 DOI: 10.1158/1078-0432.CCR-16-3224  0.01
2017 Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, et al. Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016703108. PMID 28240972 DOI: 10.1200/Jco.2016.70.3108  0.01
2017 Mahal BA, Chen YW, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Yu JB, Feng FY, Kim SP, Beard CJ, Martin NE, Trinh QD, Nguyen PL. Racial Disparities in Prostate Cancer Outcome among Prostate-Specific Antigen Screening Eligible Populations in the United States. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28174838 DOI: 10.1093/annonc/mdx041  0.01
2017 Kamran SC, Seisen T, Markt SC, Preston MA, Frazier AL, Sweeney C, Beard C. Post-orchiectomy adjuvant therapy versus surveillance for stage IS testicular cancer. Journal of Clinical Oncology. 35: 406-406. DOI: 10.1200/JCO.2017.35.6_SUPPL.406  0.01
2017 Mahal BAV, Chen Y, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE, Hu JC, Sweeney C, Beard C, Martin NE, Feng FY, Kim SP, Yu JB, Trinh Q, Nguyen PL. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. Journal of Clinical Oncology. 35: 18-18. DOI: 10.1200/JCO.2017.35.6_SUPPL.18  0.01
2017 Tripathi A, Friderici J, Preston MA, Trinh Q, Mouw K, Beard C, Bellmunt J, Stewart JA, Kibel AS, Harshman LC. Outcomes of elderly patients with muscle invasive bladder cancer (MIBC) treated with cystectomy or radiation therapy (RT): A surveillance epidemiology and end results (SEER) database analysis. Journal of Clinical Oncology. 35: e16001-e16001. DOI: 10.1200/Jco.2017.35.15_Suppl.E16001  0.01
2017 Kerns SL, Fung C, Williams A, Zaid MIA, Sesso HD, Monahan P, Ardeshirrouhanifard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger CK, Sahasrabudhe DM, et al. Clinical, sociodemographic, and behavioral factors associated with cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study. Journal of Clinical Oncology. 35: 10075-10075. DOI: 10.1200/Jco.2017.35.15_Suppl.10075  0.01
2017 Punjani N, Seisen T, Beard C, Sweeney C, Trinh Q, Rider J, Preston M. MP69-10 TRENDS IN STAGE I NON-SEMINOMATOUS GERM CELL TUMORS IN THE UNITED STATES Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.2306  0.01
2017 Muralidhar V, Mahal B, Yang D, Rose B, Beard C, Efstathiou J, King M, Martin N, Orio P, Nguyen P. Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen International Journal of Radiation Oncology*Biology*Physics. 99: S208-S209. DOI: 10.1016/j.ijrobp.2017.06.516  0.01
2017 Yang D, Mahal B, Muralidhar V, Nezolosky M, Vastola M, Labe S, Boldbaatar N, King M, Martin N, Orio P, Beard C, Trinh Q, Nguyen P. Incidence and Predictors of Upgrading and Upstaging Among 10,000 Patients with Gleason 3+4 Favorable Intermediate-Risk Prostate Cancer: Implications for Active Surveillance International Journal of Radiation Oncology*Biology*Physics. 99: E276-E277. DOI: 10.1016/J.IJROBP.2017.06.1264  0.01
2017 Kamran S, Markt S, Seisen T, Lynch S, Martin N, Nguyen P, Beard C. Bilateral Testicular Germ Cell Tumors: A SEER-Based Analysis International Journal of Radiation Oncology*Biology*Physics. 99: E245. DOI: 10.1016/j.ijrobp.2017.06.1188  0.01
2016 Miller RE, Markt SC, O'Donnell E, Bernard B, Albiges LK, Beard C, Sweeney CJ. Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy. European Urology Focus. PMID 28753801 DOI: 10.1016/j.euf.2016.10.005  0.01
2016 Muralidhar V, Mahal BA, Rose BS, Chen YW, Nezolosky MD, Efstathiou JA, Beard CJ, Martin NE, Orio PF, Trinh QD, Choueiri TK, Sweeney CJ, Nguyen PL. Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer. Clinical Genitourinary Cancer. PMID 28462857 DOI: 10.1016/j.clgc.2016.10.011  0.01
2016 Fung C, Williams A, Sesso HD, Kerns SL, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Liu H, Fossa SD, Einhorn LH, Travis LB. Cardiovascular disease (CVD) risk factors and health behaviors following cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 129. PMID 28151278 DOI: 10.1200/Jco.2016.34.3_Suppl.129  0.01
2016 Travis LB, Fung C, Sesso HD, Feldman DR, Vaughn DJ, Hamilton RJ, Johnson E, Peterson DR, Fossa SD, Einhorn LH, Beard C. Psychotropic and stimulant medication (PSM) use among testicular cancer survivors (TCS): A multi-institutional clinical study of 680 patients given cisplatin-based chemotherapy (CHEM) (NCI 1R01 CA157823-02). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 242. PMID 28151271 DOI: 10.1200/Jco.2016.34.3_Suppl.242  0.01
2016 Wheeler HE, Gamazon ER, Frisina R, Perez-Cervantes C, El Charif O, Mapes B, Fossa SD, Feldman D, Hamilton R, Vaughn DJ, Beard C, Fung C, Kollmannsberger C, Kim J, Mushiroda T, et al. Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28039263 DOI: 10.1158/1078-0432.CCR-16-2809  0.01
2016 Nguyen PL, Martin NE, Palmer-Aronsten BJ, Choeurng V, Kolisnik T, Beard CJ, Nezolosky MD, Chen YW, Shin H, Davicioni E, Feng F. The Use of a Biopsy-Based Genomic Classifier to Predict the Risk of Distant Metastasis After Definitive Radiation and Short-Course Androgen Deprivation Therapy for Intermediate- and High-Risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S113-S114. PMID 27675556 DOI: 10.1016/j.ijrobp.2016.06.279  0.01
2016 Muralidhar V, Nezolosky MD, Chen YW, Martin NE, Beard CJ, Orio PF, Nguyen PL. Association with Distance to Treatment Facility and Treatment Trends: Implications for Radiation Reimbursement Policies. International Journal of Radiation Oncology, Biology, Physics. 96: E263. PMID 27674209 DOI: 10.1016/j.ijrobp.2016.06.1282  0.01
2016 Muralidhar V, Nezolosky MD, Chen YW, Martin NE, Beard CJ, Orio PF, Nguyen PL. Adverse Pathologic Features Following Prostatectomy for Favorable High-Risk Versus Other High-Risk Prostate Cancer: Implications for Choice of Local Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E256. PMID 27674190 DOI: 10.1016/j.ijrobp.2016.06.1265  0.01
2016 Muralidhar V, Nezolosky MD, Chen YW, Martin NE, Beard CJ, Orio PF, Nguyen PL. National Trends in Androgen Deprivation Therapy Use for Prostate Cancer After Versus Before the Controversy Surrounding Cardiovascular Toxicity. International Journal of Radiation Oncology, Biology, Physics. 96: E241-E242. PMID 27674155 DOI: 10.1016/j.ijrobp.2016.06.1231  0.01
2016 Beard C, Millner AJ, Forgeard MJ, Fried EI, Hsu KJ, Treadway MT, Leonard CV, Kertz SJ, Björgvinsson T. Network analysis of depression and anxiety symptom relationships in a psychiatric sample. Psychological Medicine. 1-11. PMID 27623748 DOI: 10.1017/S0033291716002300  0.01
2016 Clerkin EM, Magee JC, Wells TT, Beard C, Barnett NP. Randomized controlled trial of attention bias modification in a racially diverse, socially anxious, alcohol dependent sample. Behaviour Research and Therapy. 87: 58-69. PMID 27591918 DOI: 10.1016/J.Brat.2016.08.010  0.01
2016 Rifkin LS, Schofield CA, Beard C, Armstrong T. Adaptation of a paradigm for examining the development of fear beliefs through the verbal information pathway in preschool-age children. Behaviour Research and Therapy. 87: 34-39. PMID 27588374 DOI: 10.1016/J.Brat.2016.08.013  0.01
2016 Chen YW, Muralidhar V, Mahal BA, Nezolosky MD, Beard CJ, Choueiri TK, Hoffman KE, Martin NE, Orio PF, Sweeney CJ, Feng FY, Trinh QD, Nguyen PL. Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer. Brachytherapy. PMID 27528590 DOI: 10.1016/j.brachy.2016.07.001  0.01
2016 Markt SC, Lago-Hernandez CA, Miller RE, Mahal BA, Bernard B, Albiges L, Frazier LA, Beard CJ, Wright AA, Sweeney CJ. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors. Cancer. PMID 27500561 DOI: 10.1002/cncr.30159  0.01
2016 LaKind JS, Overpeck J, Breysse PN, Backer L, Richardson SD, Sobus J, Sapkota A, Upperman CR, Jiang C, Beard CB, Brunkard JM, Bell JE, Harris R, Chretien JP, Peltier RE, et al. Exposure science in an age of rapidly changing climate: challenges and opportunities. Journal of Exposure Science & Environmental Epidemiology. PMID 27485992 DOI: 10.1038/Jes.2016.35  0.01
2016 Mahal BA, Chen YW, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Yu JB, Feng FY, Kim SP, Beard CJ, Martin NE, Trinh QD, Nguyen PL. National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers? Cancer. PMID 27434225 DOI: 10.1002/cncr.30205  0.01
2016 Forgeard MJ, Pearl RL, Cheung J, Rifkin LS, Beard C, Björgvinsson T. Positive beliefs about mental illness: Associations with sex, age, diagnosis, and clinical outcomes. Journal of Affective Disorders. 204: 197-204. PMID 27367308 DOI: 10.1016/J.Jad.2016.06.038  0.01
2016 Bjornsson A, Magnusdottir S, Wessman I, Beard C, Lee J, Hearon BA, Björgvinsson T. Prevalence and Characteristics of Body Dysmorphic Disorder Among Patients in a Partial Hospital Program. The Journal of Nervous and Mental Disease. 204: 554-557. PMID 27362701 DOI: 10.1097/Nmd.0000000000000543  0.01
2016 Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, et al. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27354478 DOI: 10.1200/Jco.2016.66.8822  0.01
2016 Paly JJ, Lin CC, Gray PJ, Hallemeier CL, Beard C, Sineshaw H, Jemal A, Efstathiou JA. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012. Practical Radiation Oncology. PMID 27345128 DOI: 10.1016/j.prro.2016.05.002  0.01
2016 Beard CA, Amor DJ, Di Pietro L, Archibald AD. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia. American Journal of Medical Genetics. Part A. PMID 27150953 DOI: 10.1002/ajmg.a.37697  0.01
2016 Muralidhar V, Catalano PJ, Reznor G, Mahal BA, Choueiri TK, Sweeney CJ, Martin NE, Beard CJ, Chen YW, Nezolosky MD, Hoffman KE, Feng FY, Trinh QD, Nguyen PL. Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 421-8. PMID 27059190 DOI: 10.6004/Jnccn.2016.0048  0.01
2016 Webb CA, Beard C, Kertz SJ, Hsu KJ, Björgvinsson T. Differential role of CBT skills, DBT skills and psychological flexibility in predicting depressive versus anxiety symptom improvement. Behaviour Research and Therapy. 81: 12-20. PMID 27057997 DOI: 10.1016/J.Brat.2016.03.006  0.01
2016 Beard C, Hearon BA, Lee J, Kopeski LM, Busch AB, Björgvinsson T. When Partial Hospitalization Fails: Risk Factors for Inpatient Hospitalization. The Journal of Nervous and Mental Disease. PMID 27027658 DOI: 10.1097/Nmd.0000000000000515  0.01
2016 Mahal BA, Chen YW, Efstathiou JA, Muralidhar V, Hoffman KE, Yu JB, Feng FY, Beard CJ, Martin NE, Orio PF, Nguyen PL. National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study. Cancer. PMID 26970022 DOI: 10.1002/cncr.29960  0.01
2016 Beard C, Stein AT, Hearon BA, Lee J, Hsu KJ, Björgvinsson T. Predictors of Depression Treatment Response in an Intensive CBT Partial Hospital. Journal of Clinical Psychology. PMID 26934333 DOI: 10.1002/Jclp.22269  0.01
2016 Eisen RJ, Eisen L, Beard CB. County-Scale Distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Continental United States. Journal of Medical Entomology. 53: 349-86. PMID 26783367 DOI: 10.1093/Jme/Tjv237  0.01
2016 Eisen RJ, Eisen L, Ogden NH, Beard CB. Linkages of Weather and Climate With Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae), Enzootic Transmission of Borrelia burgdorferi, and Lyme Disease in North America. Journal of Medical Entomology. 53: 250-61. PMID 26681789 DOI: 10.1093/Jme/Tjv199  0.01
2016 Lehnert MS, Beard CE, Gerard PD, Kornev KG, Adler PH. Structure of the lepidopteran proboscis in relation to feeding guild. Journal of Morphology. 277: 167-82. PMID 26589780 DOI: 10.1002/Jmor.20487  0.01
2016 Beard C, Beard V. Re-examining current breast cancer screening: An analysis of the 2009 U.S. Preventive Services Task Force guidelines for breast cancer screening. Women & Health. 56: 281-295. PMID 26362522 DOI: 10.1080/03630242.2015.1088115  0.01
2016 Muralidhar V, Xiang M, Orio PF, Martin NE, Beard CJ, Feng FY, Hoffman KE, Nguyen PL. Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer Journal of Contemporary Brachytherapy. 8: 1-6. DOI: 10.5114/jcb.2016.58080  0.01
2016 Muralidhar V, Xiang MH, Orio PF, Martin NE, Beard C, Feng FY, Hoffman KE, Nguyen PL. Brachytherapy boost and cancer-specific mortality in favorable high-risk and other high-risk prostate cancer. Journal of Clinical Oncology. 34: 52-52. DOI: 10.1200/JCO.2016.34.2_SUPPL.52  0.01
2016 Kamran SC, Curreri SA, Muralidhar V, Nguyen PL, Martin NE, Boyajian R, Harshman LC, Efstathiou JA, Beard C. Re-irradiation of the pelvis for a genitourinary second malignant neoplasm or a local recurrence after full-dose pelvic radiotherapy for a pelvic cancer: Experience in a high-volume cancer center. Journal of Clinical Oncology. 34: 494-494. DOI: 10.1200/JCO.2016.34.2_SUPPL.494  0.01
2016 Howard SAH, Rosenthal M, Qin L, Bernard BD, Beard C, Sweeney C. Quantifying decreased radiation exposure from modern CT scan surveillance programs of germ cell tumors. Journal of Clinical Oncology. 34: 478-478. DOI: 10.1200/JCO.2016.34.2_SUPPL.478  0.01
2016 El Charif O, Wheeler HE, Mushiroda T, Kubo M, Gamazon ER, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Albany C, Johnson E, Fossa S, Cox N, Einhorn LH, et al. Genome-wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors. Journal of Clinical Oncology. 34: 4543-4543. DOI: 10.1200/JCO.2016.34.15_SUPPL.4543  0.01
2016 Gamazon ER, Wheeler HE, Frisina RD, El Charif O, Mushiroda T, Kubo M, Ardeshir-Rouhani-Fard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Fossa SD, Einhorn LH, Cox N, et al. Variation in protein-coding sequence and the genetic basis of cisplatin-induced toxicities among testicular cancer survivors (TCS) in the Platinum Study. Journal of Clinical Oncology. 34: 1537-1537. DOI: 10.1200/JCO.2016.34.15_SUPPL.1537  0.01
2016 Kerns SL, Fung C, Williams A, Zaid MIA, Sesso HD, Monahan P, Ardeshir-Rouhani-Fard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Sahasrabudhe DM, Fossa SD, Einhorn LH, Travis LB. Cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study. Journal of Clinical Oncology. 34: 10089-10089. DOI: 10.1200/Jco.2016.34.15_Suppl.10089  0.01
2016 Zaid MIA, Fung C, Williams A, Sesso HD, Kerns SL, Ardeshir-Rouhani-Fard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Monahan P, Fossa SD, Einhorn LH, Travis LB. Cardiovascular disease (CVD) risk factors and health behaviors after cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS) in the Platinum study. Journal of Clinical Oncology. 34: 10087-10087. DOI: 10.1200/Jco.2016.34.15_Suppl.10087  0.01
2016 Song SJ, Beard CA, Ustinova KI. The Effects of Wearing a Compression Top on Trunk and Golf Club Motions During Golf Swing Clothing and Textiles Research Journal. 34: 48-60. DOI: 10.1177/0887302X15602096  0.01
2016 Kornev KG, Monaenkova D, Adler PH, Beard CE, Lee WK. The butterfly proboscis as a fiber-based, self-cleaning, micro-fluidic system Proceedings of Spie - the International Society For Optical Engineering. 9797. DOI: 10.1117/12.2218941  0.01
2016 Gardner MT, Cheng Y, May R, Beard C, Sterbenz J, Medhi D. Creating network resilience against disasters using Service Level Agreements Proceedings of the 2016 12th International Conference On the Design of Reliable Communication Networks, Drcn 2016. 62-70. DOI: 10.1109/DRCN.2016.7470836  0.01
2016 Wickham RE, Williamson RE, Beard CL, Kobayashi CLB, Hirst TW. Authenticity attenuates the negative effects of interpersonal conflict on daily well-being Journal of Research in Personality. 60: 56-62. DOI: 10.1016/J.Jrp.2015.11.006  0.01
2016 Chen YW, Mahal BA, Muralidhar V, Nezolosky M, Beard CJ, Den RB, Feng FY, Hoffman KE, Martin NE, Orio PF, Nguyen PL. Association between treatment at a high-volume facility and improved survival for radiation-treated men with high-risk prostate cancer International Journal of Radiation Oncology Biology Physics. 94: 683-690. DOI: 10.1016/j.ijrobp.2015.12.008  0.01
2016 Beard CL, Wickham RE. Gaming-contingent self-worth, gaming motivation, and Internet Gaming Disorder Computers in Human Behavior. 61: 507-515. DOI: 10.1016/J.Chb.2016.03.046  0.01
2016 Gardner MT, May R, Beard C, Medhi D. Determining Geographic Vulnerabilities Using a Novel Impact Based Resilience Metric Journal of Network and Systems Management. 24: 711-745. DOI: 10.1007/S10922-016-9383-Y  0.01
2016 Beard C, Fuchs C, Asnaani A, Schulson M, Schofield CA, Clerkin EM, Weisberg RB. A Pilot Open Trial of Cognitive Bias Modification for Panic Disorder Cognitive Therapy and Research. 1-7. DOI: 10.1007/S10608-016-9790-0  0.01
2016 Springer YP, Hoekman D, Johnson PTJ, Duffy PA, Hufft RA, Barnett DT, Allan BF, Amman BR, Barker CM, Barrera R, Beard CB, Beati L, Begon M, Blackmore MS, Bradshaw WE, et al. Tick-, mosquito-, and rodent-borne parasite sampling designs for the National Ecological Observatory Network Ecosphere. 7. DOI: 10.1002/Ecs2.1271  0.01
2016 Simpkin S, Brodeur J, Woods C, Leahey A, Beard C, Janzen S. Historical map digitization in libraries: Collaborative approaches for large map series Association of Canadian Map Libraries and Archives Bulletin. 11-28.  0.01
2016 Oduyebo T, Igbinosa I, Petersen EE, Polen KND, Pillai SK, Ailes EC, Villanueva JM, Newsome K, Fischer M, Gupta PM, Powers AM, Lampe M, Hills S, Arnold KE, Rose LE, ... ... Beard CB, et al. Update: Interim guidance for health care providers caring for pregnant women with possible zika virus exposure — United States, July 2016 Morbidity and Mortality Weekly Report. 65: 739-744.  0.01
2016 Muralidhar V, Catalano PJ, Reznor G, Mahal BA, Choueiri TK, Sweeney CJ, Martin NE, Beard CJ, Chen YW, Nezolosky MD, Hoffman KE, Feng FY, Trinh QD, Nguyen PL. Variation in national use of long-term ADT by disease aggressiveness among men with unfavorable-risk prostate cancer Jnccn Journal of the National Comprehensive Cancer Network. 14: 421-428.  0.01
2015 Kingry LC, Rowe LA, Respicio-Kingry LB, Beard CB, Schriefer ME, Petersen JM. Whole genome multilocus sequence typing as an epidemiologic tool for Yersinia pestis. Diagnostic Microbiology and Infectious Disease. PMID 26778487 DOI: 10.1016/J.Diagmicrobio.2015.12.003  0.01
2015 Beard C, Hsu KJ, Rifkin LS, Busch AB, Björgvinsson T. Validation of the PHQ-9 in a psychiatric sample. Journal of Affective Disorders. 193: 267-273. PMID 26774513 DOI: 10.1016/J.Jad.2015.12.075  0.01
2015 Muralidhar V, Chen MH, Reznor G, Moran BJ, Braccioforte MH, Beard CJ, Feng FY, Hoffman KE, Choueiri TK, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients. International Journal of Radiation Oncology, Biology, Physics. 93: 828-35. PMID 26530751 DOI: 10.1016/j.ijrobp.2015.07.2281  0.01
2015 Nezolosky MD, Dinh KT, Muralidhar V, Mahal BA, Chen YW, Beard CJ, Choueiri TK, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012. Urologic Oncology. PMID 26476663 DOI: 10.1016/j.urolonc.2015.09.002  0.01
2015 Rifkin LS, Beard C, Hsu KJ, Garner L, Björgvinsson T. Psychometric properties of the anxiety sensitivity index-3 in an acute and heterogeneous treatment sample. Journal of Anxiety Disorders. 36: 99-102. PMID 26460538 DOI: 10.1016/J.Janxdis.2015.09.010  0.01
2015 Dinh KT, Muralidhar V, Mahal BA, Chen YW, Nezolosky MD, Beard CJ, Choueiri TK, Martin NE, Orio PF, Sweeney CJ, Trinh QD, Nguyen PL. Occult High-Risk Disease in Clinically Low-Risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low-Risk? Urology. PMID 26391387 DOI: 10.1016/j.urology.2015.08.026  0.01
2015 Stein AT, Hearon BA, Beard C, Hsu KJ, Björgvinsson T. Properties of the Dialectical Behavior Therapy Ways of Coping Checklist in a Diagnostically Diverse Partial Hospital Sample. Journal of Clinical Psychology. PMID 26390145 DOI: 10.1002/Jclp.22226  0.01
2015 Muralidhar V, Mahal BA, Nezolosky MD, Beard CJ, Feng FY, Martin NE, Efstathiou JA, Choueiri TK, Pomerantz MM, Sweeney CJ, Trinh QD, Vander Heiden MG, Nguyen PL. Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancer. Bju International. PMID 26235660 DOI: 10.1111/bju.13248  0.01
2015 Aderka IM, Beard C, Lee J, Weiss RB, Björgvinsson T. The relationship between depression and generalized anxiety during intensive psychological and pharmacological treatment. Journal of Affective Disorders. 184: 261-268. PMID 26118754 DOI: 10.1016/J.Jad.2015.05.054  0.01
2015 Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, et al. Testicular Cancer, Version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 772-99. PMID 26085393 DOI: 10.6004/Jnccn.2015.0092  0.01
2015 Curreri SA, Fung C, Beard CJ. Secondary malignant neoplasms in testicular cancer survivors. Urologic Oncology. 33: 392-8. PMID 26072728 DOI: 10.1016/j.urolonc.2015.05.002  0.01
2015 Monaghan AJ, Moore SM, Sampson KM, Beard CB, Eisen RJ. Climate change influences on the annual onset of Lyme disease in the United States. Ticks and Tick-Borne Diseases. PMID 26025268 DOI: 10.1016/j.ttbdis.2015.05.005  0.01
2015 Bell CL, Yu D, Smolke CD, Geall AJ, Beard CW, Mason PW. Control of alphavirus-based gene expression using engineered riboswitches. Virology. 483: 302-311. PMID 26005949 DOI: 10.1016/J.Virol.2015.04.023  0.01
2015 Lago-Hernandez CA, Feldman H, O'Donnell E, Mahal BA, Perez V, Howard S, Rosenthal M, Cheng SC, Nguyen PL, Beard C, D'Amico AV, Sweeney CJ. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 1396-401. PMID 25888612 DOI: 10.1093/Annonc/Mdv180  0.01
2015 Muralidhar V, Mahal BA, Ziehr DR, Chen YW, Nezolosky MD, Viswanathan VB, Beard CJ, Devlin PM, Martin NE, Orio PF, Nguyen PL. Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer. Brachytherapy. 14: 511-6. PMID 25887342 DOI: 10.1016/j.brachy.2015.03.004  0.01
2015 Hearon BA, Garner L, Beard C, Björgvinsson T. Predictors of Suicidality Among Patients with Psychotic Disorders in a Partial Hospital Treatment Program. Suicide & Life-Threatening Behavior. 45: 710-9. PMID 25871863 DOI: 10.1111/Sltb.12165  0.01
2015 Dinh KT, Mahal BA, Ziehr DR, Muralidhar V, Chen YW, Viswanathan VB, Nezolosky MD, Beard CJ, Choueiri TK, Martin NE, Orio PF, Sweeney CJ, Trinh QD, Nguyen PL. Risk of prostate cancer mortality in men with a history of prior cancer. Bju International. PMID 25845283 DOI: 10.1111/bju.13144  0.01
2015 Clerkin EM, Beard C, Fisher CR, Schofield CA. An attempt to target anxiety sensitivity via cognitive bias modification. Plos One. 10: e0114578. PMID 25692491 DOI: 10.1371/Journal.Pone.0114578  0.01
2015 Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, et al. Kidney cancer, version 3.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 151-9. PMID 25691606 DOI: 10.6004/Jnccn.2015.0022  0.01
2015 Dinh KT, Mahal BA, Ziehr DR, Muralidhar V, Chen YW, Viswanathan VB, Nezolosky MD, Beard CJ, Choueiri TK, Martin NE, Orio PF, Sweeney CJ, Trinh QD, Nguyen PL. Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer. The Journal of Urology. PMID 25681290 DOI: 10.1016/j.juro.2015.02.015  0.01
2015 Mahal BA, Cooperberg MR, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Orio PF, Trinh QD, Nguyen PL. Who bears the greatest burden of aggressive treatment of indolent prostate cancer? The American Journal of Medicine. 128: 609-16. PMID 25644324 DOI: 10.1016/j.amjmed.2014.12.030  0.01
2015 Mahal BA, Inverso G, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hoffman KE, Hu JC, Beard CJ, D'Amico AV, Martin NE, Orio PF, Trinh QD, Nguyen PL. Incidence and determinants of 1-month mortality after cancer-directed surgery. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 399-406. PMID 25430935 DOI: 10.1093/annonc/mdu534  0.01
2015 Alosco ML, Gunstad J, Beard C, Xu X, Clark US, Labbe DR, Jerskey BA, Ladino M, Cote DM, Walsh EG, Poppas A, Cohen RA, Sweet LH. The synergistic effects of anxiety and cerebral hypoperfusion on cognitive dysfunction in older adults with cardiovascular disease. Journal of Geriatric Psychiatry and Neurology. 28: 57-66. PMID 25009160 DOI: 10.1177/0891988714541871  0.01
2015 Markt SC, Miller R, O'Donnell E, Albiges L, Bernard BD, Lago-Hernandez C, Curreri SA, Wright AA, Beard C, Sweeney C. BMI at diagnosis and adverse outcomes among men with malignant testicular germ cell tumors. Journal of Clinical Oncology. 33: 400-400. DOI: 10.1200/JCO.2015.33.7_SUPPL.400  0.01
2015 Curreri SA, Markt SC, Miller R, O'Donnell E, Bernard BD, Kamran SC, Albiges L, Wright AA, Sweeney C, Beard C. Bilateral testicular germ cell tumors. Journal of Clinical Oncology. 33: 392-392. DOI: 10.1200/JCO.2015.33.7_SUPPL.392  0.01
2015 Kamran SC, Markt SC, Miller R, O'Donnell E, Bernard BD, Curreri SA, Albiges LK, Sweeney C, Beard C. A review of clinical stage 1 testicular cancer mortality in a high-volume center. Journal of Clinical Oncology. 33: 390-390. DOI: 10.1200/JCO.2015.33.7_SUPPL.390  0.01
2015 Miller R, Markt SC, O'Donnell E, Bernard BD, Albiges L, Lago-Hernandez C, Curreri SA, Beard C, Wright AA, Sweeney C. Association of age 40 and older with adverse outcome in metastatic testicular cancer (TC). Journal of Clinical Oncology. 33: 386-386. DOI: 10.1200/jco.2015.33.7_suppl.386  0.01
2015 Dinh KT, Mahal BAV, Ziehr DR, Muralidhar V, Chen Y, Viswanathan VB, Nezolosky MD, Beard C, Choueiri TK, Orio PF, Martin NE, Sweeney C, Trinh Q, Nguyen PL. Incidence and predictors of prostate cancer death in men with other prior malignancies: An analysis from SEER Database. Journal of Clinical Oncology. 33: 34-34. DOI: 10.1200/JCO.2015.33.7_SUPPL.34  0.01
2015 Bernard BD, Markt SC, Albiges L, Miller R, Pettersson A, Beard C, Sweeney C. Sunlight and testicular germ cell tumor rates in the USA. Journal of Clinical Oncology. 33: e15565-e15565. DOI: 10.1200/JCO.2015.33.15_SUPPL.E15565  0.01
2015 Bernard BD, Markt SC, Albiges L, Miller R, Beard C, Sweeney C. Melanoma risk in men with testicular germ cell tumors in the United States. Journal of Clinical Oncology. 33: e15554-e15554. DOI: 10.1200/JCO.2015.33.15_SUPPL.E15554  0.01
2015 Gebremichail AA, Beard C. Multi-hop relay selection based on fade durations Wireless Telecommunications Symposium. 2015. DOI: 10.1109/WTS.2015.7117248  0.01
2015 Gardner MT, May R, Beard C, Medhi D. Finding geographic vulnerabilities in multilayer networks using reduced network state enumeration 2015 11th International Conference On the Design of Reliable Communication Networks, Drcn 2015. 49-56. DOI: 10.1109/DRCN.2015.7148984  0.01
2015 Cohen M, Beard C, Björgvinsson T. Examining Patient Characteristics as Predictors of Patient Beliefs About Treatment Credibility and Expectancies for Treatment Outcome Journal of Psychotherapy Integration. DOI: 10.1037/A0038878  0.01
2015 Ziehr DR, Mahal BA, Aizer AA, Hyatt AS, Beard CJ, D'Amico AV, Choueiri TK, Elfiky A, Lathan CS, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Income inequality and treatment of African American men with high-risk prostate cancer Urologic Oncology: Seminars and Original Investigations. 33: 18.e7-18.e13. DOI: 10.1016/j.urolonc.2014.09.005  0.01
2015 Harshman LC, Preston MA, Bellmunt J, Beard C. Diagnosis of Bladder Carcinoma: A Clinician's Perspective Surgical Pathology Clinics. 8: 677-685. DOI: 10.1016/j.path.2015.07.004  0.01
2015 Hsu KJ, Beard C, Rifkin L, Dillon DG, Pizzagalli DA, Björgvinsson T. Transdiagnostic mechanisms in depression and anxiety: The role of rumination and attentional control Journal of Affective Disorders. 188: 22-27. DOI: 10.1016/j.jad.2015.08.008  0.01
2015 Muralidhar V, Mahal B, Ziehr D, Chen Y, Nezolosky M, Viswanathan V, Beard C, Devlin P, Martin N, Orio P, Nguyen P. Shifting Brachytherapy Monotherapy Case Mix Toward Intermediate-Risk Prostate Cancer: Implications for Future Directions of Research International Journal of Radiation Oncology*Biology*Physics. 93: E354-E355. DOI: 10.1016/J.IJROBP.2015.07.1451  0.01
2015 Gardner MT, May R, Beard C, Medhi D. A Geographic Multi-Topology Routing approach and its benefits during large-scale geographically correlated failures Computer Networks. 82: 34-49. DOI: 10.1016/J.Comnet.2015.02.024  0.01
2015 Weiss RB, Aderka IM, Lee J, Beard C, Björgvinsson T. A Comparison of Three Brief Depression Measures in an Acute Psychiatric Population: CES-D-10, QIDS-SR, and DASS-21-DEP Journal of Psychopathology and Behavioral Assessment. 37: 217-230. DOI: 10.1007/S10862-014-9461-Y  0.01
2015 Hayes B, Lissenberg CJ, Bédard JH, Beard C. The geochemical effects of olivine slurry replenishment and dolostone assimilation in the plumbing system of the Franklin Large Igneous Province, Victoria Island, Arctic Canada Contributions to Mineralogy and Petrology. 169. DOI: 10.1007/s00410-015-1117-8  0.01
2015 Green TGA, Seppelt RD, Brabyn LR, Beard C, Türk R, Lange OL. Flora and vegetation of Cape Hallett and vicinity, northern Victoria Land, Antarctica Polar Biology. 38: 1825-1845. DOI: 10.1007/s00300-015-1744-6  0.01
2015 Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, et al. Testicular cancer, version 2.2015: Clinical pactice guidelines in oncology Jnccn Journal of the National Comprehensive Cancer Network. 13: 772-799. DOI: 10.1007/978-3-642-54859-8_57  0.01
2015 Sanders L, Adler P, Beard C, Kornev KG. Mechanical characterization of lepidoptera proboscises through tensile testing Fiber Society 2015 Fall Meeting and Technical Conference - Fibers: Where Tradition Meets Innovation 0.01
2015 Gardner MT, Beard C, Van De Liefvoort A. Mission critical publish-subscribe performance modeling using linear algebraic and classical methods Simulation Series. 47: 269-277.  0.01
2015 Beard C, Brodeur J, Janzen S, Leahey A, Simpkin S. Ontario's historical topographic map digitization project Association of Canadian Map Libraries and Archives Bulletin. 19-22.  0.01
2015 Beard CJ, Gupta S, Motzer RJ, O'Donnell EK, Plimack ER, Margolin KA, Ryan CJ, Sheinfeld J, Feldman DR. Follow-up management of patients with testicular cancer: A multidisciplinary consensus-based approach Jnccn Journal of the National Comprehensive Cancer Network. 13: 811-822.  0.01
2014 Inverso G, Aizer AA, Ziehr DR, Hyatt A, Choueiri TK, Hoffman KE, Hu JC, Beard C, D'Amico AV, Martin NE, Orio PF, Trinh QD, Nguyen PL. Incidence and determinants of 1-month mortality after cancer-directed surgery. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 282. PMID 28141239 DOI: 10.1200/jco.2014.32.30_suppl.282  0.01
2014 Howard SA, Gray KP, O'Donnell EK, Fennessy FM, Beard CJ, Sweeney CJ. Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor. Ajr. American Journal of Roentgenology. 203: W415-20. PMID 25247970 DOI: 10.2214/AJR.13.11615  0.01
2014 Webb CA, Beard C, Auerbach RP, Menninger E, Björgvinsson T. The therapeutic alliance in a naturalistic psychiatric setting: temporal relations with depressive symptom change. Behaviour Research and Therapy. 61: 70-7. PMID 25156322 DOI: 10.1016/J.Brat.2014.07.015  0.01
2014 Ziehr DR, Chen MH, Zhang D, Braccioforte MH, Moran BJ, Mahal BA, Hyatt AS, Basaria SS, Beard CJ, Beckman JA, Choueiri TK, D'Amico AV, Hoffman KE, Hu JC, Martin NE, et al. Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer. Bju International. PMID 25124891 DOI: 10.1111/bju.12905  0.01
2014 Molins CR, Sexton C, Young JW, Ashton LV, Pappert R, Beard CB, Schriefer ME. Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation. Journal of Clinical Microbiology. 52: 3755-62. PMID 25122862 DOI: 10.1128/JCM.01409-14  0.01
2014 Brito LA, Chan M, Shaw CA, Hekele A, Carsillo T, Schaefer M, Archer J, Seubert A, Otten GR, Beard CW, Dey AK, Lilja A, Valiante NM, Mason PW, Mandl CW, et al. A cationic nanoemulsion for the delivery of next-generation RNA vaccines. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 2118-29. PMID 25027661 DOI: 10.1038/Mt.2014.133  0.01
2014 Beard C, Björgvinsson T. Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample. Journal of Anxiety Disorders. 28: 547-52. PMID 24983795 DOI: 10.1016/J.Janxdis.2014.06.002  0.01
2014 Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Lago-Hernandez C, Chen YW, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Trinh QD, Nguyen PL. The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act. Prostate Cancer and Prostatic Diseases. 17: 273-9. PMID 24980272 DOI: 10.1038/pcan.2014.23  0.01
2014 Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Sammon JD, Schmid M, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Trinh QD, Nguyen PL. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups. Urology. 84: 386-92. PMID 24975710 DOI: 10.1016/j.urology.2014.05.009  0.01
2014 Tsai CC, Monaenkova D, Beard CE, Adler PH, Kornev KG. Paradox of the drinking-straw model of the butterfly proboscis. The Journal of Experimental Biology. 217: 2130-8. PMID 24920837 DOI: 10.1242/Jeb.097998  0.01
2014 Mahal BA, Ziehr DR, Hyatt AS, Neubauer-Sugar EH, O'Farrell DA, O'Leary MP, Steele GS, Niedermayr TR, Beard CJ, Martin NE, Orio PF, D'Amico AV, Devlin PM, Nguyen PL. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results. Brachytherapy. 13: 442-9. PMID 24880584 DOI: 10.1016/j.brachy.2014.05.001  0.01
2014 Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Lago-Hernandez C, Choueiri TK, Elfiky AA, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Lathan CS, Trinh QD, et al. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer. Journal of Geriatric Oncology. 5: 352-8. PMID 24862107 DOI: 10.1016/j.jgo.2014.05.001  0.01
2014 Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC, Hoffman KE, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Trinh QD, Nguyen PL. Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer. Clinical Genitourinary Cancer. 12: e189-95. PMID 24861952 DOI: 10.1016/j.clgc.2014.04.003  0.01
2014 Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Sammon JD, Schmid M, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Lathan C, Kim SP, Trinh QD, et al. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Urologic Oncology. 32: 1285-91. PMID 24846344 DOI: 10.1016/j.urolonc.2014.04.014  0.01
2014 Wen Y, Monroe J, Linton C, Archer J, Beard CW, Barnett SW, Palladino G, Mason PW, Carfi A, Lilja AE. Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice. Vaccine. 32: 3796-804. PMID 24837507 DOI: 10.1016/J.Vaccine.2014.05.004  0.01
2014 Fennessy FM, McKay RR, Beard CJ, Taplin ME, Tempany CM. Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls. Translational Oncology. 7: 120-9. PMID 24772215 DOI: 10.1593/tlo.13922  0.01
2014 Bjornsson AS, Sibrava NJ, Beard C, Moitra E, Weisberg RB, Benítez CI, Keller MB. Two-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder with agoraphobia in a sample of Latino adults. Journal of Consulting and Clinical Psychology. 82: 1186-92. PMID 24731232 DOI: 10.1037/A0036565  0.01
2014 Seible DM, Gu X, Hyatt AS, Beard CJ, Choueiri TK, Efstathiou JA, Miyamoto DT, Mitin T, Martin NE, Sweeney CJ, Trinh QD, Beckman JA, Basaria S, Nguyen PL. Weight gain on androgen deprivation therapy: which patients are at highest risk? Urology. 83: 1316-21. PMID 24726149 DOI: 10.1016/J.Urology.2014.02.006  0.01
2014 Martin NE, Chen MH, Beard CJ, Nguyen PL, Loffredo MJ, Renshaw AA, Kantoff PW, D'Amico AV. Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators. Prostate Cancer. 2014: 912943. PMID 24701353 DOI: 10.1155/2014/912943  0.01
2014 Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, Feldman DR, Pagliaro LC, Miller RC, Vaughn DJ, Einhorn LH, Cox NJ, Dolan ME. Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics. Journal of the National Cancer Institute. 106. PMID 24623533 DOI: 10.1093/jnci/dju044  0.01
2014 Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, et al. Kidney cancer, version 2.2014. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 175-82. PMID 24586079 DOI: 10.6004/Jnccn.2014.0018  0.01
2014 Weisberg RB, Beard C, Moitra E, Dyck I, Keller MB. Adequacy of treatment received by primary care patients with anxiety disorders. Depression and Anxiety. 31: 443-50. PMID 24190762 DOI: 10.1002/Da.22209  0.01
2014 Kovtun KA, Wolfsberger L, Niedermayr T, Sugar EN, Graham PL, Murciano-Goroff Y, Beard C, D'Amico AV, Martin NE, Orio PF, Nguyen PL. Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: implications for the use of newer isotopes. Brachytherapy. 13: 152-6. PMID 23911279 DOI: 10.1016/j.brachy.2013.05.006  0.01
2014 Kwauk KJ, Hasegawa DK, Lehnert MS, Beard CE, Gerard PD, Kornev KG, Adler PH. Drinking with an unsealed tube: Fluid uptake along the butterfly proboscis Annals of the Entomological Society of America. 107: 886-892. DOI: 10.1603/An14027  0.01
2014 Seible DM, Gu X, Hyatt A, Beard C, Efstathiou JA, Miyamoto DT, Mitin T, Martin NE, Beckman J, Basaria S, Nguyen PL. Identifying men at greatest risk of weight gain from androgen deprivation therapy. Journal of Clinical Oncology. 32: 80-80. DOI: 10.1200/Jco.2014.32.4_Suppl.80  0.01
2014 Mahal BA, Ziehr DR, Hyatt A, Aizer AA, Sammon JD, Schmid M, Choueiri TK, Hoffman KE, Hu JC, Sweeney C, Beard C, D'Amico AV, Martin NE, Lathan CS, Kim SP, et al. The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Journal of Clinical Oncology. 32: 5091-5091. DOI: 10.1200/JCO.2014.32.15_SUPPL.5091  0.01
2014 O'Donnell E, Feldman H, Lago-Hernandez C, Hirsch MS, Beard C, Van Allen EM, Kantoff PW, Sweeney C. Tumor genomic mutation profiling of germ cell tumors using “Profile”. Journal of Clinical Oncology. 32: 4516-4516. DOI: 10.1200/JCO.2014.32.15_SUPPL.4516  0.01
2014 Tekinay M, Beard C, Medhi D. Exploiting characteristics of slow fading channels in OFDMA scheduling Iwcmc 2014 - 10th International Wireless Communications and Mobile Computing Conference. 901-906. DOI: 10.1109/IWCMC.2014.6906475  0.01
2014 Gardner MT, May R, Beard C, Medhi D. Using multi-topology routing to improve routing during geographically correlated failures Drcn 2014 - Proceedings, 10th International Conference On Design of Reliable Communication Networks. DOI: 10.1109/DRCN.2014.6816134  0.01
2014 Wilson JP, Beard C. Constructing a sustainable learning organization: Marks and Spencer's first Plan A learning store Learning Organization. 21: 98-112. DOI: 10.1108/TLO-08-2012-0056  0.01
2014 Martin R, Brabyn L, Beard C. Effects of class granularity and cofactors on the performance of unsupervised classification of wetlands using multi-spectral aerial photography Journal of Spatial Science. 59: 269-282. DOI: 10.1080/14498596.2014.913272  0.01
2014 Beard C, Humberstone B, Clayton B. Positive emotions: Passionate scholarship and student transformation Teaching in Higher Education. 19: 630-643. DOI: 10.1080/13562517.2014.901950  0.01
2014 Beard C, Jeldres C, Odem-Davis K, Hoffman K, Martin N, Nguyen P, Porter C, Sweeney C, Kollmannsberger C, Nichols C. Variation in Patterns of Care in the United States for Clinical Stage I Seminoma: Results From the National Cancer Data Base (1998-2011) International Journal of Radiation Oncology*Biology*Physics. 90: S469. DOI: 10.1016/J.IJROBP.2014.05.1459  0.01
2014 Mahal B, Aizer A, Ziehr D, Hyatt A, Choueiri T, Jim H, Hoffman K, Sweeney C, Beard C, D'Amico A, Martin N, Kim S, Trinh Q, Nguyen P. The Impact of Race on Prostate-Cancer Specific Mortality Among Men With Low-Risk Disease: Potential Implications for Active Surveillance International Journal of Radiation Oncology*Biology*Physics. 90: S448. DOI: 10.1016/J.IJROBP.2014.05.1404  0.01
2014 Mahal B, Aizer A, Ziehr D, Hyatt A, Sammon J, Schmid M, Choueiri T, Hoffman K, Hu J, Sweeney C, Beard C, D'Amico A, Martin N, Kim S, Trinh Q, et al. Racial Disparities in the Management of African American Men With Intermediate- to High-Risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S446. DOI: 10.1016/J.IJROBP.2014.05.1399  0.01
2014 Ziehr DR, Chen M, Zhang D, Braccioforte MH, Moran BJ, Mahal BA, Hyatt AS, Beard CJ, D'Amico AV, Hoffman KE, Martin NE, Nguyen PL. Association of Androgen Deprivation Therapy with Excess Cardiovascular-Specific Mortality in Men with Prostate Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.100  0.01
2014 Beard C. Late effects in testicular cancer survivors Pediatric Oncology. 1: 115-131. DOI: 10.1007/978-3-642-38971-9_8  0.01
2014 Gardner MT, Beard C, Van De Liefvoort A. Efficient matrix-exponential random variate generation using a numeric linear combination approach Simulation Series. 46: 133-140.  0.01
2013 Chen MH, Beard C, Nguyen PL, Loffredo M, Renshaw AA, Kantoff PW, D'Amico AV. Age, comorbidity, and the risk of death in men with PSA failure following radiation therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 82. PMID 28137129 DOI: 10.1200/Jco.2013.31.6_Suppl.82  0.01
2013 Paly JJ, Zietman AL, Nguyen PL, Beard C, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Multidisciplinary care and management of very low-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 55. PMID 28137047 DOI: 10.1200/jco.2013.31.6_suppl.55  0.01
2013 Gray KP, Hirsch MS, Ravi P, Beard C, Sweeney C. A 10-year retrospective review of germ cell tumors not cured with cisplatin-based chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 325. PMID 28136929 DOI: 10.1200/jco.2013.31.6_suppl.325  0.01
2013 Wolfsberger LD, Niedermayr T, Neubauer E, Murciano-Goroff YR, Beard C, D'Amico AV, Martin NE, Orio PF, Nguyen PL. Dosimetic quality and evolution of edema after prostate brachytherapy for small prostates: Implications for the use of newer isotopes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 232. PMID 28136851 DOI: 10.1200/jco.2013.31.6_suppl.232  0.01
2013 Paly JJ, Efstathiou JA, Hedgire SS, Chung PW, O'Malley M, Shah A, Bekelman JE, Harisinghani M, Zietman AL, Beard C. Mapping patterns of nodal metastases in seminoma: rethinking radiotherapy fields. Practical Radiation Oncology. 3: S30. PMID 24674542 DOI: 10.1016/j.prro.2013.01.103  0.01
2013 Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Models of care and NCCN guideline adherence in very-low-risk prostate cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 11: 1364-72. PMID 24225970  0.01
2013 Maruggi G, Shaw CA, Otten GR, Mason PW, Beard CW. Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity. Virology. 447: 254-64. PMID 24210122 DOI: 10.1016/j.virol.2013.07.021  0.01
2013 Sibrava NJ, Beard C, Bjornsson AS, Moitra E, Weisberg RB, Keller MB. Two-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder in a longitudinal sample of African American adults. Journal of Consulting and Clinical Psychology. 81: 1052-62. PMID 24041233 DOI: 10.1037/A0034382  0.01
2013 Nichols CR, Roth B, Albers P, Einhorn LH, Foster R, Daneshmand S, Jewett M, Warde P, Sweeney CJ, Beard C, Powles T, Tyldesley S, So A, Porter C, Olgac S, et al. Active surveillance is the preferred approach to clinical stage I testicular cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3490-3. PMID 24002502 DOI: 10.1200/JCO.2012.47.6010  0.01
2013 Parekh A, Chen MH, D'Amico AV, Dosoretz DE, Ross R, Salenius S, Graham PL, Beckman JA, Beard CJ, Choueiri TK, Ennis RD, Hoffman KE, Hu JC, Ma J, Martin NE, et al. Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer. Brachytherapy. 12: 415-21. PMID 23651926 DOI: 10.1016/j.brachy.2013.02.005  0.01
2013 Beard CJ, Travis LB, Chen MH, Arvold ND, Nguyen PL, Martin NE, Kuban DA, Ng AK, Hoffman KE. Outcomes in stage I testicular seminoma: a population-based study of 9193 patients. Cancer. 119: 2771-7. PMID 23633409 DOI: 10.1002/cncr.28086  0.01
2013 Hoegele W, Loeschel R, Dobler B, Koelbl O, Beard C, Zygmanski P. Stochastic triangulation for prostate positioning during radiotherapy using short CBCT arcs. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 106: 241-9. PMID 23395068 DOI: 10.1016/j.radonc.2013.01.005  0.01
2013 Paly JJ, Efstathiou JA, Hedgire SS, Chung PW, O'Malley M, Shah A, Bekelman JE, Harisinghani M, Shipley WU, Zietman AL, Beard C. Mapping patterns of nodal metastases in seminoma: rethinking radiotherapy fields. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 106: 64-8. PMID 23321493 DOI: 10.1016/j.radonc.2012.12.002  0.01
2013 Nguyen PL, Devlin PM, Beard CJ, Orio PF, O'Leary MP, Wolfsberger LD, O'Farrell DA, Sweeney CM, Hadaschik BA, Hohenfellner M, Hatiboglu G. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. Brachytherapy. 12: 77-83. PMID 22543116 DOI: 10.1016/j.brachy.2012.03.005  0.01
2013 Shi Z, Beard C. QoS in the mobile cloud computing environment Mobile Networks and Cloud Computing Convergence For Progressive Services and Applications. 200-217. DOI: 10.4018/978-1-4666-4781-7.ch011  0.01
2013 Beard C, Chen ZQ, Kumar V, Lee Y, Leon-Salas WD, Rao P. SAVEUS: Saving victims in earthquakes through unified systems International Journal of Communication Networks and Distributed Systems. 10: 402-420. DOI: 10.1504/Ijcnds.2013.054259  0.01
2013 O'Donnell E, Gray KP, Hirsch MS, Kantoff PW, Beard C, Sweeney C. Smoking history and disease outcomes in patients with malignant germ cell tumors. Journal of Clinical Oncology. 31: 4561-4561. DOI: 10.1200/jco.2013.31.15_suppl.4561  0.01
2013 Beard C, Björgvinsson T. Psychological vulnerability: An integrative approach Journal of Psychotherapy Integration. 23: 281-283. DOI: 10.1037/A0032361  0.01
2012 Aizer A, Paly JJ, Zietman AL, D'Amico AV, Nguyen PL, Beard C, Rao SK, Kaplan ID, Hirsch MS, Wu CL, Efstathiou JA. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 131. PMID 27968168 DOI: 10.1200/jco.2012.30.5_suppl.131  0.01
2012 Nguyen PL, Chen MH, Zhang Y, Tempany CM, Cormack RA, Beard C, Hurwitz MD, Suh WW, D'Amico AV. Long-term results of MRI-guided partial prostate brachytherapy for favorable-risk prostate cancer: Implications for focal therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 114. PMID 27967968 DOI: 10.1200/Jco.2012.30.5_Suppl.114  0.01
2012 Paly JJ, Efstathiou JA, Hedgire S, Chung PW, O'Malley M, Shah A, Bekelman JE, Harisinghani M, Zietman AL, Shipley WU, Beard C. Mapping patterns of nodal metastases in seminoma: Rethinking radiotherapy fields. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 324. PMID 27967953 DOI: 10.1200/jco.2012.30.5_suppl.324  0.01
2012 Katz LM, Efstathiou JA, Opraseuth J, Killoran J, Paly JJ, Weathers R, Stovall M, Beard C. Normal tissue exposure during retroperitoneal radiotherapy for pure seminoma of the testis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 334. PMID 27967911 DOI: 10.1200/jco.2012.30.5_suppl.334  0.01
2012 Kishan AU, Chen MH, Loffredo M, Kim D, Beard CJ, Hurwitz MD, Martin NE, Orio PF, Kantoff PW, D'Amico AV, Nguyen PL. Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation. Practical Radiation Oncology. 2: 172-8. PMID 24674120 DOI: 10.1016/J.Prro.2011.08.002  0.01
2012 Nguyen PL, Chen MH, Zhang Y, Tempany CM, Cormack RA, Beard CJ, Hurwitz MD, Suh WW, D'Amico AV. Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy. The Journal of Urology. 188: 1151-6. PMID 22901567 DOI: 10.1016/J.Juro.2012.06.010  0.01
2012 Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3071-6. PMID 22851571 DOI: 10.1200/JCO.2012.42.8466  0.01
2012 Martin NE, Chen MH, Nguyen PL, Beard CJ, Loffredo MJ, Kantoff PW, D'Amico AV. Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade. Bju International. 110: 1252-6. PMID 22564379 DOI: 10.1111/J.1464-410X.2012.11118.X  0.01
2012 Tseng YD, Chen MH, Beard CJ, Martin NE, Orio PF, Loffredo M, Renshaw AA, Choueiri TK, Hu JC, Kantoff PW, D'Amico AV, Nguyen PL. Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality. The Journal of Urology. 187: 2068-73. PMID 22498212 DOI: 10.1016/j.juro.2012.01.073  0.01
2012 Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, et al. Testicular cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 502-35. PMID 22491049  0.01
2012 Wilder RB, Buyyounouski MK, Efstathiou JA, Beard CJ. Radiotherapy treatment planning for testicular seminoma International Journal of Radiation Oncology Biology Physics. 83. PMID 22436787 DOI: 10.1016/j.ijrobp.2012.01.044  0.01
2012 Arvold ND, Catalano PJ, Sweeney CJ, Hoffman KE, Nguyen PL, Balboni TA, FossÃ¥ SD, Travis LB, Beard CJ. Barriers to the implementation of surveillance for stage I testicular seminoma. International Journal of Radiation Oncology, Biology, Physics. 84: 383-9. PMID 22349043 DOI: 10.1016/J.Ijrobp.2011.11.064  0.01
2012 Sprauten M, Darrah TH, Peterson DR, Campbell ME, Hannigan RE, Cvancarova M, Beard C, Haugnes HS, Fosså SD, Oldenburg J, Travis LB. Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 300-7. PMID 22184390 DOI: 10.1200/Jco.2011.37.4025  0.01
2012 Nguyen PL, Chen MH, Beckman JA, Beard CJ, Martin NE, Choueiri TK, Hu JC, Hoffman KE, Dosoretz DE, Moran BJ, Salenius SA, Braccioforte MH, Kantoff PW, D'Amico AV, Ennis RD. Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction. International Journal of Radiation Oncology, Biology, Physics. 82: 1411-6. PMID 21708431 DOI: 10.1016/j.ijrobp.2011.04.067  0.01
2012 Aizer A, Paly J, Zietman A, Beard C, Nguyen P, Kaplan I, Hirsch M, Wu C, D'Amico A, Efstathiou J. Physician Bias, Referral to a Medical Oncologist, and Active Surveillance in Low-risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S182. DOI: 10.1016/J.IJROBP.2012.07.470  0.01
2012 Katz L, Efstathiou J, Hoffman K, Paly J, Opraseuth J, Killoran J, Weathers R, Stovall M, Beard C. Impact of Radiation Field Design on Inadvertent Cardiac and Kidney Dose Delivered During Treatment for Stage I/II Seminoma International Journal of Radiation Oncology*Biology*Physics. 84: S421. DOI: 10.1016/J.IJROBP.2012.07.1113  0.01
2011 Beard C, Chen M, Arvold ND, Nguyen PL, Ng AK, Hoffman KE. Long-term survival and competing causes of death in men with stage I seminoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 226. PMID 27968699 DOI: 10.1200/Jco.2011.29.7_Suppl.226  0.01
2011 Arvold ND, Catalano PJ, Sweeney C, Hoffman KE, Nguyen PL, Balboni TA, Fossa SD, Travis LB, Beard C. Physician and patient factors influencing management recommendations in stage I testicular seminoma: A survey among radiation oncologists in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 225. PMID 27968685 DOI: 10.1200/Jco.2011.29.7_Suppl.225  0.01
2011 Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Carducci MA, Chang SS, Choueiri TK, Hancock SL, Hudes GR, Jonasch E, Josephson D, Kuzel TM, Levine EG, Lin DW, et al. Kidney cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 960-77. PMID 21917622  0.01
2011 Nguyen PL, Chen MH, Goldhaber SZ, Martin NE, Beard CJ, Dosoretz DE, Katin MJ, Ross R, Salenius SA, D'Amico AV. Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation. Cancer. 117: 406-13. PMID 21108457 DOI: 10.1002/cncr.25597  0.01
2011 Beard C, Stason WB, Wang Q, Manola J, Dean-Clower E, Dusek JA, Decristofaro S, Webster A, Doherty-Gilman AM, Rosenthal DS, Benson H. Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer. Cancer. 117: 96-102. PMID 20803609 DOI: 10.1002/cncr.25291  0.01
2011 Nguyen PL, Chen MH, Choueiri TK, Hoffman KE, Hu JC, Martin NE, Beard CJ, Dosoretz DE, Moran BJ, Katin MJ, Braccioforte MH, Ross R, Salenius SA, Kantoff PW, D'Amico AV. Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size. International Journal of Radiation Oncology, Biology, Physics. 79: 1318-22. PMID 20605366 DOI: 10.1016/j.ijrobp.2010.01.023  0.01
2011 Tseng YD, Chen M, Loffredo M, Kantoff PW, Beard CJ, Martin NE, Orio PF, D'Amico AV, Nguyen PL. Post-Treatment Prostate-Specific Antigen Nadir is Predictive of All-Cause Mortality: A Reanalysis of the Dana Farber Cancer Institute Radiation With or Without Androgen Deprivation Therapy Randomized Trial International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.681  0.01
2011 Aizer A, Paly J, Zietman A, Nguyen P, Beard C, Rao S, Kaplan I, Hirsch M, Wu C, Efstathiou J. Referral to a Multidisciplinary Genitourinary Oncology Clinic Increases Rates of Active Surveillance in Low-risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S101-S102. DOI: 10.1016/J.IJROBP.2011.06.208  0.01
2011 Paly J, Efstathiou J, Hedgire S, Harisinghani M, Zietman A, Beard C. Mapping Patterns of Nodal Metastases in Seminoma: Rethinking the Para-aortic Field International Journal of Radiation Oncology*Biology*Physics. 81: S44-S45. DOI: 10.1016/J.IJROBP.2011.06.090  0.01
2010 Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, et al. Testicular cancer survivorship: research strategies and recommendations. Journal of the National Cancer Institute. 102: 1114-30. PMID 20585105 DOI: 10.1093/Jnci/Djq216  0.01
2010 Nguyen PL, Chen MH, Beard CJ, Suh WW, Choueiri TK, Efstathiou JA, Hoffman KE, Loffredo M, Kantoff PW, D'Amico AV. Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence. Cancer. 116: 610-5. PMID 19957321 DOI: 10.1002/cncr.24818  0.01
2010 Nguyen PL, Chen MH, Beard CJ, Suh WW, Renshaw AA, Loffredo M, McMahon E, Kantoff PW, D'Amico AV. Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group. International Journal of Radiation Oncology, Biology, Physics. 77: 1046-52. PMID 19864082 DOI: 10.1016/J.Ijrobp.2009.06.038  0.01
2010 Sprauten M, Darrah T, Hannigan R, Beard C, Haugnes H, Cvancarova M, Peterson D, Travis L, Fosså S, Oldenburg J. 603 Long-term accumulation of platinum (Pt) and its impact on self-reported neuro- and ototoxicity in cisplatin-treated testicular cancer survivors (TCSs) European Journal of Cancer Supplements. 8: 153-154. DOI: 10.1016/S1359-6349(10)71404-X  0.01
2010 Nguyen P, Chen M, Dosoretz D, Moran B, Salenius S, Braccioforte M, Beard C, Hoffman K, D'Amico A, Ennis R. The Adverse Impact of Androgen Deprivation Therapy on All-cause Mortality in Men with High-risk Prostate Cancer and a History of Congestive Heart Failure (CHF) or Myocardial Infarction (MI) International Journal of Radiation Oncology*Biology*Physics. 78: S350. DOI: 10.1016/J.IJROBP.2010.07.827  0.01
2010 Arvold N, Catalano P, Sweeney C, Hoffman K, Nguyen P, Balboni T, Fosså S, Travis L, Beard C. Patterns of Care for Stage I Seminoma: A Survey of American Radiation Oncologists International Journal of Radiation Oncology*Biology*Physics. 78: S193. DOI: 10.1016/J.Ijrobp.2010.07.469  0.01
2010 Beard CJ, Chen M, Arvold ND, Nguyen PL, Ng AK, Hoffman KE. Long-term Survival and Competing Causes of Death in Men with Stage I Seminoma International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.173  0.01
2010 Chen R, Chen M, Zhang Y, McMahon E, Loffredo M, Nguyen P, Beard C, D'Amico A. Patient-reported Quality of Life (QOL) in Unfavorable-Risk Prostate Cancer: Sexual Function Recovery after External Beam Radiation (RT) and 6 months of Androgen Deprivation International Journal of Radiation Oncology*Biology*Physics. 78: S603. DOI: 10.1016/J.Ijrobp.2010.07.1403  0.01
2009 Lin NU, Kasparian E, Morganstern DE, Beard C. Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e218-9. PMID 19786662 DOI: 10.1200/JCO.2009.22.7868  0.01
2009 Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, et al. NCCN clinical practice guidelines in oncology: testicular cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 7: 672-93. PMID 19555582 DOI: 10.6004/JNCCN.2009.0047  0.01
2009 Nguyen P, Chen M, Beard C, Suh W, Choueiri T, Efstathiou J, Hoffman K, Loffredo M, Kantoff P, D'Amico A. Comorbidity, Body Mass Index, and Age and the Risk of Non-prostate Cancer-specific Mortality following a Postradiation PSA Recurrence International Journal of Radiation Oncology*Biology*Physics. 75: S495. DOI: 10.1016/J.IJROBP.2009.07.1130  0.01
2008 Hoffman KE, Chen MH, Punglia RS, Beard CJ, D'Amico AV. Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3937-42. PMID 18711182 DOI: 10.1200/JCO.2008.16.5043  0.01
2008 Sommers BD, Beard CJ, D'Amico AV, Kaplan I, Richie JP, Zeckhauser RJ. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer. 113: 2058-67. PMID 18704993 DOI: 10.1002/Cncr.23807  0.01
2008 Albert M, Song JS, Schultz D, Cormack RA, Tempany CM, Haker S, Devlin PM, Beard C, Hurwitz MD, Suh WW, Jolesz F, D'Amico AV. Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate. Urologic Oncology. 26: 147-52. PMID 18312933 DOI: 10.1016/J.Urolonc.2007.03.026  0.01
2007 Sommers BD, Beard CJ, D'Amico AV, Dahl D, Kaplan I, Richie JP, Zeckhauser RJ. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer. Cancer. 110: 2210-7. PMID 17893907 DOI: 10.1002/Cncr.23028  0.01
2007 Pomerantz M, Manola J, Taplin ME, Bubley G, Inman M, Lowell J, Beard C, Kantoff PW, Oh WK. Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer. The Journal of Urology. 177: 2146-50. PMID 17509304 DOI: 10.1016/j.juro.2007.01.119  0.01
2007 Beard C, Dean-Clower E, Dusek J, Stason WB, DeCristofaro S, Keshaviah A, Purevjal I, Rosenthal D, Webster A, Benson H. A study of complementary therapies in men receiving radiation therapy for prostate cancer: A randomized feasibility trial Journal of Clinical Oncology. 25: 15638-15638. DOI: 10.1200/jco.2007.25.18_suppl.15638  0.01
2006 Nakabayashi M, Beard C, Kelly SM, Carr-Locke DL, Oh WK. Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer. Urologic Oncology. 24: 503-8. PMID 17138131 DOI: 10.1016/j.urolonc.2006.02.002  0.01
2006 Beard C, Schultz D, Loffredo M, Cote K, Renshaw AA, Hurwitz MD, D'Amico AV. Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 66: 403-7. PMID 16765530 DOI: 10.1016/j.ijrobp.2006.03.033  0.01
2006 D'Amico AV, Manola J, McMahon E, Loffredo M, Lopes L, Ching J, Albert M, Hurwitz M, Suh WW, Vivenzio TA, Beard C. A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization. Urology. 67: 780-4. PMID 16584760 DOI: 10.1016/J.UROLOGY.2005.10.008  0.01
2005 Beard C, Chen M, Cote K, Loffredo M, Renshaw A, Hurwitz M, D’Amico AV. Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer. Urology. 66: 1020-1023. PMID 16286116 DOI: 10.1016/J.Urology.2005.05.039  0.01
2005 Tsai HK, Manola J, Abner A, Talcott JA, D'Amico AV, Beard C. Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy. Urologic Oncology. 23: 230-7. PMID 16018937 DOI: 10.1016/j.urolonc.2005.02.005  0.01
2005 Beard CJ. The risk of bladder, bowel, and sexual dysfunction after radiation therapy: What the data tell us and how we can use it to counsel our patients Cancer Journal. 11: 106-109. PMID 15969984 DOI: 10.1097/00130404-200503000-00004  0.01
2005 Woel R, Beard C, Chen M, Hurwitz M, Loffredo M, McMahon E, Ching J, Lopes L, D’Amico AV. Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization International Journal of Radiation Oncology Biology Physics. 62: 392-396. PMID 15890580 DOI: 10.1016/J.Ijrobp.2004.10.003  0.01
2005 Landis DM, Schultz D, Cormack R, Tempany C, Beard C, Hurwitz M, O'Leary M, Albert M, Valentine K, D'Amico AV. Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy. Urology. 65: 750-4. PMID 15833521 DOI: 10.1016/j.urology.2004.10.044  0.01
2005 Suh W, Loffredo M, Schultz D, Cormack R, Tempany C, Beard C, Hurwitz M, Albert M, D′Amico A. Late Toxicity and Early Prostate-Specific Antigen Outcome Following Salvage Prostate Brachytherapy for Select Patients Following Primary Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 63: S290. DOI: 10.1016/J.IJROBP.2005.07.495  0.01
2004 D'Amico AV, Renshaw AA, Cote K, Hurwitz M, Beard C, Loffredo M, Chen MH. Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease Journal of Clinical Oncology. 22: 3726-3732. PMID 15365069 DOI: 10.1200/Jco.2004.01.164  0.01
2004 Sanghani MV, Ching J, Schultz D, Cormack R, Loffredo M, McMahon E, Beard C, D'Amico AV. Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy. Urologic Oncology. 22: 165-8. PMID 15271308 DOI: 10.1016/j.urolonc.2004.02.002  0.01
2004 Beard CJ, Chen MH, Cote K, Loffredo M, Renshaw AA, Hurwitz M, D'Amico AV. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer International Journal of Radiation Oncology Biology Physics. 58: 19-24. PMID 14697416 DOI: 10.1016/S0360-3016(03)01433-0  0.01
2004 Kwon RS, Beard C, D'Amico AV, Carr-Locke DL. Comparison of Safety and Outcome Between Two Argon Plasma Coagulation Settings for Radiation Proctopathy in Patients with Prostate Cancer Gastrointestinal Endoscopy. 59: P271. DOI: 10.1016/S0016-5107(04)01202-7  0.01
2004 Woel RF, Beard C, Chen M, Hurwitz M, Loffredo M, McMahon E, Ching J, Lopes L, D’Amico AV. Acute gastrointestinal, genitourinary, and dermatologic toxicity during dose escalated 3DCRT using an intra-rectal balloon for prostate gland localization and immobilization International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.07.559  0.01
2004 Landis D, Schultz D, Beard C, Hurwitz M, Tempany C, Cormack R, D’Amico A. Acute urinary retention following magnetic-resonance-image-guided prostate brachytherapy International Journal of Radiation Oncology*Biology*Physics. 60: S568-S569. DOI: 10.1016/J.IJROBP.2004.07.554  0.01
2004 Tsai H, Manola J, Abner A, Talcott J, D’Amico A, Beard C. Patient-reported acute gastrointestinal and genitourinary toxicities during conventional dose 3-dimensional conformal radiation therapy for adenocarcinoma of the prostate planned following neoadjuvant hormonal therapy International Journal of Radiation Oncology*Biology*Physics. 60: S567-S568. DOI: 10.1016/J.IJROBP.2004.07.552  0.01
2004 D'Amico AV, Renshaw AA, Cote K, Hurwitz M, Beard C, Loffredo M, Chen M. The impact of the percent of positive prostate biopsies on prostate cancer-specific mortality for patients with low or favorable intermediate risk disease International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.07.353  0.01
2004 Beard C, Schultz D, Loffredo M, Cote K, Renshaw A, Hurwitz M, D’Amico A. The clinical impact of perineural invasion on cancer-specific mortality following external beam radiation therapy for men with low- and favorable intermediate-risk prostate cancer International Journal of Radiation Oncology*Biology*Physics. 60: S429. DOI: 10.1016/J.IJROBP.2004.07.323  0.01
2003 D'amico AV, Tempany CM, Schultz D, Cormack RA, Hurwitz M, Beard C, Albert M, Kooy H, Jolesz F, Richie JP. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology. 62: 1063-7. PMID 14665356 DOI: 10.1016/S0090-4295(03)00772-6  0.01
2003 Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, Chen RC, O'Leary MP, Kantoff PW, D'Amico AV. Time course and predictors of symptoms after primary prostate cancer therapy Journal of Clinical Oncology. 21: 3979-3986. PMID 14581420 DOI: 10.1200/JCO.2003.01.199  0.01
2003 Albert M, Tempany CM, Schultz D, Chen MH, Cormack RA, Kumar S, Hurwitz MD, Beard C, Tuncali K, O'Leary M, Topulos GP, Valentine K, Lopes L, Kanan A, Kacher D, et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer. 98: 949-54. PMID 12942561 DOI: 10.1002/Cncr.11595  0.01
2003 Pellegrino B, Terrier-Lacombe MJ, Oberlin O, Leblanc T, Perel Y, Bertrand Y, Beard C, Edan C, Schmitt C, Plantaz D, Pacquement H, Vannier JP, Lambilliote C, Couillault G, Babin-Boilletot A, et al. Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric Oncology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 2948-52. PMID 12885814 DOI: 10.1200/JCO.2003.01.079  0.01
2002 Coleman CN, Kelly L, Riese Daly N, Beard C, Kaplan I, Lamb C, Propert K, Manola J. Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects. International Journal of Radiation Oncology, Biology, Physics. 54: 191-4. PMID 12182991 DOI: 10.1016/S0360-3016(02)02907-3  0.01
2002 Hurwitz MD, Schnieder L, Manola J, Beard CJ, Kaplan ID, D'Amico AV. Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: A retrospective analysis International Journal of Radiation Oncology Biology Physics. 53: 1106-1110. PMID 12128108 DOI: 10.1016/S0360-3016(02)02885-7  0.01
2001 D'Amico AV, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer International Journal of Radiation Oncology Biology Physics. 49: 679-684. PMID 11172949 DOI: 10.1016/S0360-3016(00)01423-1  0.01
2001 Killoran JH, Baldini EH, Beard CJ, Chin L. A technique for optimization of digitally reconstructed radiographs of the chest in virtual simulation International Journal of Radiation Oncology Biology Physics. 49: 231-239. PMID 11163520 DOI: 10.1016/S0360-3016(00)01362-6  0.01
2001 Hurwitz M, Schneider L, Manola J, Beard C, Kaplan I, D’Amico A. Assessment of freedom from biochemical failure for low risk clinically localized prostate cancer patients supports use of conventional dose radiation in this patient population International Journal of Radiation Oncology*Biology*Physics. 51: 287-288. DOI: 10.1016/S0360-3016(01)02350-1  0.01
2000 D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer Journal of the American Medical Association. 284: 1280-1283. PMID 10979115 DOI: 10.1001/JAMA.284.10.1280  0.01
2000 D'Amico A, Schultz D, Lofreddo M, Hurwitz M, Kaplan I, Beard C, Renshaw A, Kantoff P. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for patients with clinically localized prostate cancer International Journal of Radiation Oncology*Biology*Physics. 48: 171. DOI: 10.1016/S0360-3016(00)80135-2  0.01
1999 D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer Journal of Clinical Oncology. 17: 168-172. PMID 10458230 DOI: 10.1200/JCO.1999.17.1.168  0.01
1999 Kaplan I, Jiroutek M, Henry DL, Beard CJ, D'Amico AV. Postprostatectomy External Beam Irradiation The Prostate Journal. 1: 32-37. DOI: 10.1046/j.1525-1411.1999.00005.x  0.01
1998 D'Amico AV, Whittington R, Bruce Malkowicz S, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer Journal of the American Medical Association. 280: 969-974. PMID 9749478 DOI: 10.1001/jama.280.11.969  0.01
1998 D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Loughlin KR, Richie JP, Wein A. Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy Journal of Clinical Oncology. 16: 3094-3100. PMID 9738580 DOI: 10.1200/JCO.1998.16.9.3094  0.01
1998 Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, D'Amico A, Kaplan I. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer International Journal of Radiation Oncology Biology Physics. 41: 257-262. PMID 9607338 DOI: 10.1016/S0360-3016(98)00054-6  0.01
1998 Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 275-83. PMID 9440753 DOI: 10.1200/Jco.1998.16.1.275  0.01
1998 D'Amico AV, Whittington R, Malkowicz SB, Blank K, Broderick GA, Schultz D, Tomaszewski JE, Kaplan I, Beard CJ, Wein A, Coleman CN. 5 year biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer International Journal of Radiation Oncology*Biology*Physics. 42: 301. DOI: 10.1016/S0360-3016(98)80454-9  0.01
1997 Wong JS, Recht A, Beard CJ, Busse PM, Cady B, Chaffey JT, Come S, Fam S, Kaelin C, Lingos TI, Nixon AJ, Shulman LN, Troyan S, Silver B, Harris JR. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes International Journal of Radiation Oncology Biology Physics. 39: 915-920. PMID 9369141 DOI: 10.1016/S0360-3016(97)00456-2  0.01
1997 D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV. International Journal of Radiation Oncology, Biology, Physics. 39: 335-40. PMID 9308936 DOI: 10.1016/S0360-3016(97)00320-9  0.01
1997 Kim HK, Jessup JM, Beard CJ, Bornstein B, Cady B, Stone MD, Bleday R, Bothe A, Steele G, Busse PM. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 38: 777-83. PMID 9240646 DOI: 10.1016/S0360-3016(97)89476-X  0.01
1997 D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek M, Malkowicz SB, Wein A, Coleman CN. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml. International Journal of Radiation Oncology, Biology, Physics. 37: 1053-8. PMID 9169812 DOI: 10.1016/S0360-3016(96)00633-5  0.01
1997 Killoran JH, Kooy HM, Gladstone DJ, Welte FJ, Beard CJ. A numerical simulation of organ motion and daily setup uncertainties: implications for radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 37: 213-21. PMID 9054898 DOI: 10.1016/S0360-3016(96)00477-4  0.01
1997 Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, Talcott JA. Complications after treatment with external-beam irradiation in early- stage prostate cancer patients: A prospective multiinstitutional outcomes study Journal of Clinical Oncology. 15: 223-229. PMID 8996146 DOI: 10.1200/Jco.1997.15.1.223  0.01
1997 D'Amico A, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz S, Tomaszewski J, Wein A, Coleman C. 1002 Equivalent 5 year bNED in select prostate cancer patients managed with surgery or radiation therapy despit exclusion of the seminal vesicles from the clinical target volume International Journal of Radiation Oncology*Biology*Physics. 39: 216. DOI: 10.1016/S0360-3016(97)80720-1  0.01
1996 Beard CJ, Kijewski P, Bussière M, Gelman R, Gladstone D, Shaffer K, Plunkett M, Castello P, Coleman CN. Analysis of prostate and seminal vesicle motion: implications for treatment planning. International Journal of Radiation Oncology, Biology, Physics. 34: 451-8. PMID 8567348 DOI: 10.1016/0360-3016(95)02081-0  0.01
1996 Wong J, Nixon A, Recht A, Beard C, Busse P, Chaffey J, Lingos T, Silver B, Harris M. 114 Treatment outcome after tangential radiotherapy alone without axillary dissection in patients with early stage breast cancer with clinically negative axillary nodes International Journal of Radiation Oncology*Biology*Physics. 36: 215. DOI: 10.1016/S0360-3016(97)85455-7  0.01
1995 Watkins-Bruner D, Scott C, Lawton C, DelRowe J, Rotman M, Buswell L, Beard C, Cella D. RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 33: 901-6. PMID 7591900 DOI: 10.1016/0360-3016(95)02002-5  0.01
1994 Coleman CN, Beard CJ, Kantoff PW, Gelman R. Rate of relapse following treatment for localized prostate cancer: a critical analysis of retrospective reports. International Journal of Radiation Oncology, Biology, Physics. 28: 303-13. PMID 8270455 DOI: 10.1016/0360-3016(94)90171-6  0.01
1994 Beard C, Buswell L, Rose MA, Noll L, Johnson D, Coleman CN. Phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 29: 611-6. PMID 7516321 DOI: 10.1016/0360-3016(94)90467-7  0.01
1993 Busse PM, Clark JR, Beard CJ, Dreyfuss AI, Lucarini JW, Rossi R, Casey D, Norris CM. Primary site management following induction chemotherapy with cis- platinum, 5-fluorouracil, and leucovorin Head and Neck. 15: 413-418. PMID 8407313 DOI: 10.1002/HED.2880150508  0.01
1993 Beard CJ, Kaplan ID, Norman Coleman C. The challenge for conformal therapy for prostate cancer International Journal of Radiation Oncology, Biology, Physics. 26: 705-707. PMID 8331005 DOI: 10.1016/0360-3016(93)90293-5  0.01
1993 Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, Tung N, Wheeler C, Beard CJ, Canellos GP, Shulman LN. Large-cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients Journal of Clinical Oncology. 11: 1336-1343. PMID 8315431 DOI: 10.1200/JCO.1993.11.7.1336  0.01
1992 Shafman TD, Beard CJ, Silver B, Mauch P. Prognostic factors in stage I and II diffuse large cell lymphoma patients treated with multiagent chemotherapy alone or combined with radiation therapy International Journal of Radiation Oncology*Biology*Physics. 24: 227. DOI: 10.1016/0360-3016(92)90305-2  0.01
1992 Busse P, Beard C, Clark J, Norris C, Dreyfuss A, Lucarini J, Rossi R, Casey D, Miller D. Radiation as primary site management following induction chemotherapy with CIS-platinum, 5-FU, and leucovorin (PFL) International Journal of Radiation Oncology*Biology*Physics. 24: 199. DOI: 10.1016/0360-3016(92)90260-O  0.01
1991 Busse P, Clark J, Norris C, Dreyfuss A, Beard C, Lucarini J, Andersen J, Casey D, Miller D. Regional control after induction chemotherapy for adbanced squamous cell carcinoma of the head and neck: A retrospective analysis of 303 patients International Journal of Radiation Oncology*Biology*Physics. 21: 219. DOI: 10.1016/0360-3016(91)90621-A  0.01
Hide low-probability matches.